5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T14980 | CLK-IN-T3 | DYRK , CDK | |
CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity. | |||
T8801 | SRI-29329 | CDK | |
SRI-29329 is a potent, specific inhibitor of CDC-like kinase (with IC50 of 78 nM, 16 nM and 86 nM for CLK1, CLK2 and CLK4, respectively). | |||
T39608 | Cirtuvivint | SM08502 | CDK |
Cirtuvivint (SM08502) is a potent and orally active CDC-like kinase (CLK) inhibitor that can be used to study arthritis. | |||
T73943 | CLK-IN-T3N | ||
CLK-IN-T3N, the negative control of CLK-IN-T3 , is a chemical probe for CDC-like kinase (CLK) . | |||
T36684 | Ipivivint | ||
Ipivivint, a first-in-class, orally active and potent CDC-like kinase (CLK) inhibitor, inhibits CLK1 (IC50=1.4 μM), CLK2 (IC50=0.002 μM) and CLK3 (IC50=0.022 μM). Ipivivint reduces Wnt pathway signaling gene expression t... |